Showing 1 - 6 results of 6 for search 'Harpreet S Takhar', query time: 0.03s Refine Results
  1. 1
    Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study

    Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study by Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng

    Published 2022-02-01
    Get full text
    Article
  2. 2
    Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine

    Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine by Lina S. Sy, Kristin I. Meyer, Nicola P. Klein, Chun Chao, Christine Velicer, T. Craig Cheetham, Bradley K. Ackerson, Jeff M. Slezak, Harpreet S. Takhar, John Hansen, Kamala Deosaransingh, Kai-Li Liaw, Steven J. Jacobsen

    Published 2018-02-01
    Get full text
    Article
  3. 3
    Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

    Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 by Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Sijia Qiu, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna D. Paila, Scott Chavers, Carla A. Talarico, Lei Qian

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data

    Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data by Ana Florea, Joan A Casey, Keeve Nachman, Lance B Price, Magdalena E Pomichowski, Harpreet S Takhar, Vanessa Quinlivan, Lee D Childs, Meghan F Davis, Rong Wei, Vennis Hong, Jennifer H Ku, Cindy M Liu, Alice Pressman, Sarah Robinson, Katia J Bruxvoort, S Bianca Salas, Sara Y Tartof

    Published 2023-05-01
    Get full text
    Article
  5. 5
    mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States

    mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States by Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, Julia E. Tubert, Yi Luo, Sijia Qiu, Gina S. Lee, Katia J. Bruxvoort, Jennifer H. Ku, Ana Florea, Harpreet S. Takhar, Radha Bathala, Cindy Ke Zhou, Daina B. Esposito, Morgan A. Marks, Evan J. Anderson, Carla A. Talarico, Lei Qian

    Published 2023-09-01
    Get full text
    Article
  6. 6
    Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages

    Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages by Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng

    Published 2024-12-01
    Get full text
    Article

Search Tools: